Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project. [PDF]
Abruzzese E +31 more
europepmc +1 more source
Monografie. La Facoltà di Architettura "Aldo Rossi" a Cesena.
Il volume raccoglie le ricerche svolte all'interno della Facoltà di Architettura "Aldo Rossi" dell'Università di Bologna - sede di ...
I. Clemente
core
Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience. [PDF]
Catapano AL +6 more
europepmc +1 more source
Aldo Rossi. Il Teatro del Mondo 1979-2004
Documentario video sul Teatro del Mondo di Aldo Rossi ricostruito in occasione della mostra Arti & Architettura tenutasi a ...
FERA, FRANCESCO SAVERIO, D. Zanasi
core
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis). [PDF]
Trovato E +33 more
europepmc +1 more source
Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology. [PDF]
Conticello C +43 more
europepmc +1 more source
Progression rate of diverticular disease and associated risk factors: results from 5-year longitudinal prospective nationwide diverticular disease registry (REMAD). [PDF]
Carabotti M +8 more
europepmc +1 more source
Correction: Castagna et al. Sodium Chloride Cotransporter in Hypertension. <i>Biomedicines</i> 2024, <i>12</i>, 2580. [PDF]
Castagna A +6 more
europepmc +1 more source
Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care? [PDF]
Tarantini F +30 more
europepmc +1 more source

